0000950170-23-064579.txt : 20231116 0000950170-23-064579.hdr.sgml : 20231116 20231116173520 ACCESSION NUMBER: 0000950170-23-064579 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230608 FILED AS OF DATE: 20231116 DATE AS OF CHANGE: 20231116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Encrantz Staffan CENTRAL INDEX KEY: 0001870875 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40587 FILM NUMBER: 231415687 MAIL ADDRESS: STREET 1: C/O SIGHT SCIENCES, INC. STREET 2: 4040 CAMPBELL AVENUE, SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sight Sciences, Inc. CENTRAL INDEX KEY: 0001531177 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 800625749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 105 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (415) 889-0550 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 105 CITY: MENLO PARK STATE: CA ZIP: 94025 4/A 1 ownership.xml 4/A X0508 4/A 2023-06-08 2023-06-12 0001531177 Sight Sciences, Inc. SGHT 0001870875 Encrantz Staffan C/O SIGHT SCIENCES, INC. 4040 CAMPBELL AVE., SUITE 100 MENLO PARK CA 94025 true false true false false Common Stock 2023-06-08 4 A false 11940 0 A 11940 D Common Stock 2023-06-08 4 A false 15094 0 A 27034 D Common Stock 1184258 I See footnote Common Stock 4022118 I See footnote Reflects the vesting in full of 11,940 restricted stock units ("RSUs") granted to the Reporting Person on June 8, 2022 under the Issuer's Non-Employee Director Compensation Program (the "Program"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 5, 2022. Each RSU represented a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). Reflects a grant of RSUs made to the Reporting Person under the Program. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Issuer's board of directors through such vesting date. These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any. These shares include 632,456 shares of Common Stock that were previously distributed by Allegro Investors LLC to the Trust (its sole member) for no consideration. These shares of Common Stock are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President of Allegro Investment Inc., the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund. The Reporting Person disclaims beneficial ownership of the shares held by Allegro Investment Fund (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any. This amendment is being filed to report the shares of Common Stock, that were beneficially owned by the Reporting Person as of June 12, 2023, which were inadvertently omitted in the original Form 4. /s/ Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz 2023-11-16